Daiki Kato 研究室
主宰者:Daiki Kato
東京大学
兼任:名古屋大学
AI 要約(直近 5 年の研究成果)
Daiki Kato研究室は、動物と人間の疾患に関する複数の領域で研究を展開しています。主要な研究テーマの一つは、悪性腫瘍の転移メカニズムの解明です。特に犬の粘膜黒色腫やウシ骨肉腫といった動物モデルを用いて、腫瘍細胞がどのようにして組織内を移動し、遠隔転移を起こすのかを調べています。細胞レベルでのタンパク質発現や細胞内シグナル伝達経路を解析することで、腫瘍の進行と予後に関連する分子機構を明らかにしようとしています。
別の主要テーマは、小児外科領域における最小侵襲手術の安全性と治療成績の向上です。腹腔鏡を用いた手術技術の習得過程における患者安全性の確保、最適な手術アプローチの開発、ならびに術後管理における電解質や水分管理の最適化などについて、臨床データの後ろ向き分析を通じて検討しています。胆道閉鎖症やその他の先天的疾患に対する手術方法の改善に取り組んでいます。
さらに、犬の膀胱尿路上皮癌や腸器官といった動物の泌尿器疾患・消化器疾患に対する外科的治療法の開発と成績評価も行われています。これらの動物での治療成績は、ヒトの同様の疾患治療法の開発に向けた知見をもたらす可能性があります。
※ AI(Claude)が、公開されている論文要旨から研究の問い・手法・主要な発見を事実情報として抽出・再構成して自動生成しています。誤りを含む可能性があるため、正確性は研究室公式情報でご確認ください。
外部リンク
関連研究室(8 件)
- 医学Katsutoshi Oda 研究室University of Tokyo Hospital論文 101 件·共通: がん, 医学・健康科学, 生物学, 分子・細胞 +6
- 医学Issei Komuro 研究室University of Tokyo Hospital論文 100 件·共通: 心臓, 医学・健康科学, 循環器・呼吸器, 循環器 +5
- 生化学・分子生物学・遺伝学Takashi Ito 研究室九州大学論文 56 件·共通: 生物学, 分子・細胞, 分子, RNA +7
- 医学Masaomi Nangaku 研究室東京大学論文 100 件·共通: 生物学, 医学・健康科学, 分子・細胞, 分子 +4
- 生化学・分子生物学・遺伝学Masakazu Toi 研究室京都大学論文 100 件·共通: OS, 情報工学, 計算機科学, システム +6
- 神経科学Jun Yamada 研究室九州大学論文 52 件·共通: 転移, 医学・健康科学, がん, がん進展 +6
- 免疫学・微生物学Takashi Ishida 研究室名古屋大学論文 27 件·共通: 生物学, 分子・細胞, がん, 医学・健康科学 +6
- 生化学・分子生物学・遺伝学Ryozo Nagai 研究室University of Tokyo Hospital論文 25 件·共通: 分子, 生物学, 分子・細胞, 免疫 +6
研究成果(188 件)
- DOI: https://doi.org/10.1299/jsmekansai.2025.100.20203
- DOI: https://doi.org/10.1292/jvms.25-0253
- [2025] Supplementary Figure 1 from Podoplanin Drives Amoeboid Invasion in Canine and Human Mucosal MelanomaDOI: https://doi.org/10.1158/1541-7786.30903211
- DOI: https://doi.org/10.1292/jvms.25-0253
- [2025] Supplementary Figure 3 from Podoplanin Drives Amoeboid Invasion in Canine and Human Mucosal MelanomaDOI: https://doi.org/10.1158/1541-7786.30903196
- DOI: https://doi.org/10.1158/1541-7786.30903175
- [2025] Supplementary Table 1 from Podoplanin Drives Amoeboid Invasion in Canine and Human Mucosal MelanomaDOI: https://doi.org/10.1158/1541-7786.30903169
- [2025] Supplementary Figure 9 from Podoplanin Drives Amoeboid Invasion in Canine and Human Mucosal MelanomaDOI: https://doi.org/10.1158/1541-7786.30903178
- [2025] Supplementary Figure 7 from Podoplanin Drives Amoeboid Invasion in Canine and Human Mucosal MelanomaDOI: https://doi.org/10.1158/1541-7786.30903184
- DOI: https://doi.org/10.1007/s00595-025-03203-x
続きを表示(残り 178 件)閉じる
- [2025] Supplementary Figure 1 from Podoplanin Drives Amoeboid Invasion in Canine and Human Mucosal MelanomaDOI: https://doi.org/10.1158/1541-7786.30903211
- [2025] Supplementary Figure 3 from Podoplanin Drives Amoeboid Invasion in Canine and Human Mucosal MelanomaDOI: https://doi.org/10.1158/1541-7786.30903196
- [2025] Supplementary Table 1 from Podoplanin Drives Amoeboid Invasion in Canine and Human Mucosal MelanomaDOI: https://doi.org/10.1158/1541-7786.30903169
- [2025] Supplementary Figure 9 from Podoplanin Drives Amoeboid Invasion in Canine and Human Mucosal MelanomaDOI: https://doi.org/10.1158/1541-7786.30903178
- DOI: https://doi.org/10.1016/j.jvsvi.2025.100329
- DOI: https://doi.org/10.1292/jvms.25-0285
- DOI: https://doi.org/10.1038/s41598-025-22749-x
- DOI: https://doi.org/10.1016/j.xjon.2025.10.004
- DOI: https://doi.org/10.1007/s11701-025-02782-8
- DOI: https://doi.org/10.1016/j.jvsvi.2025.100329
- DOI: https://doi.org/10.1038/s41598-025-22749-x
- DOI: https://doi.org/10.1016/j.xjon.2025.10.004
- DOI: https://doi.org/10.1371/journal.pone.0332825
- DOI: https://doi.org/10.1111/jce.70040
- DOI: https://doi.org/10.1007/s00595-025-03203-x
- DOI: https://doi.org/10.1007/s00392-025-02714-4
- DOI: https://doi.org/10.1371/journal.pone.0332825
- DOI: https://doi.org/10.20965/ijat.2025.p0949
- DOI: https://doi.org/10.1111/cas.70169
- DOI: https://doi.org/10.1016/j.surg.2025.109596
- DOI: https://doi.org/10.20965/ijat.2025.p0949
- DOI: https://doi.org/10.1016/j.surg.2025.109596
- DOI: https://doi.org/10.1111/jce.70040
- DOI: https://doi.org/10.4103/jmas.jmas_218_24
- DOI: https://doi.org/10.1111/ases.70128
- DOI: https://doi.org/10.1292/jvms.24-0201
- DOI: https://doi.org/10.4103/jmas.jmas_218_24
- DOI: https://doi.org/10.1007/s00464-025-11657-w
- DOI: https://doi.org/10.21037/tau-2024-662
- [2025] Supplementary Figure 2 from Podoplanin Drives Amoeboid Invasion in Canine and Human Mucosal MelanomaDOI: https://doi.org/10.1158/1541-7786.30903199
- DOI: https://doi.org/10.1007/s00464-025-11657-w
- DOI: https://doi.org/10.1292/jvms.24-0201
- DOI: https://doi.org/10.1111/ped.70016
- DOI: https://doi.org/10.1111/ped.70016
- DOI: https://doi.org/10.1111/ases.70128
- DOI: https://doi.org/10.1007/s00383-024-05724-x
- DOI: https://doi.org/10.1117/12.3050589
- DOI: https://doi.org/10.21037/jtd-24-987
- DOI: https://doi.org/10.1117/12.3050538
- DOI: https://doi.org/10.4326/jjcvs.53.333
- DOI: https://doi.org/10.4326/jjcvs.53.333
- DOI: https://doi.org/10.1117/12.3050589
- DOI: https://doi.org/10.1111/vco.12999
- [2024] First pediatric pelvic surgery with the <scp>Senhance</scp> ® robotic surgical system: A case seriesDOI: https://doi.org/10.1111/ases.13379
- DOI: https://doi.org/10.1007/s00383-024-05800-2
- DOI: https://doi.org/10.1111/vco.12999
- [2024] First pediatric pelvic surgery with the <scp>Senhance</scp> ® robotic surgical system: A case seriesDOI: https://doi.org/10.1111/ases.13379
- DOI: https://doi.org/10.1007/s00383-024-05800-2
- DOI: https://doi.org/10.1111/pace.15093
- DOI: https://doi.org/10.1002/jpn3.12349
- DOI: https://doi.org/10.1016/j.jpedsurg.2024.07.037
- DOI: https://doi.org/10.1115/isfa2024-141057
- DOI: https://doi.org/10.1007/s00383-024-05786-x
- DOI: https://doi.org/10.3390/diseases12060122
- DOI: https://doi.org/10.1007/s00383-024-05724-x
- DOI: https://doi.org/10.1002/jpn3.12349
- DOI: https://doi.org/10.1016/j.jpedsurg.2024.07.037
- DOI: https://doi.org/10.1115/isfa2024-141057
- DOI: https://doi.org/10.1007/s00383-024-05786-x
- DOI: https://doi.org/10.3390/diseases12060122
- DOI: https://doi.org/10.1186/s40792-024-01875-0
- DOI: https://doi.org/10.4028/p-t0jikm
- DOI: https://doi.org/10.1111/vco.12970
- DOI: https://doi.org/10.4326/jjcvs.53.49
- [2024] Table of ContentsDOI: https://doi.org/10.1016/s0022-3468(24)00040-x
- DOI: https://doi.org/10.1299/jsmekansai.2024.99.20603
- DOI: https://doi.org/10.1186/s40792-024-01875-0
- DOI: https://doi.org/10.4028/p-t0jikm
- DOI: https://doi.org/10.1111/vco.12970
- DOI: https://doi.org/10.4326/jjcvs.53.49
- [2024] Table of ContentsDOI: https://doi.org/10.1016/s0022-3468(24)00040-x
- DOI: https://doi.org/10.1299/jsmekansai.2024.99.20603
- DOI: https://doi.org/10.1016/j.ncrna.2024.01.017
- DOI: https://doi.org/10.1080/01652176.2023.2300943
- DOI: https://doi.org/10.1016/j.tvjl.2024.106064
- DOI: https://doi.org/10.1292/jvms.23-0094
- DOI: https://doi.org/10.18178/ijmerr.13.2.278-283
- DOI: https://doi.org/10.1299/jsmermd.2024.2p2-l06
- DOI: https://doi.org/10.1016/j.ncrna.2024.01.017
- DOI: https://doi.org/10.1080/01652176.2023.2300943
- DOI: https://doi.org/10.1016/j.tvjl.2024.106064
- DOI: https://doi.org/10.1292/jvms.23-0094
- DOI: https://doi.org/10.18178/ijmerr.13.2.278-283
- DOI: https://doi.org/10.1299/jsmermd.2024.2p2-l06
- DOI: https://doi.org/10.1186/s40792-023-01754-0
- DOI: https://doi.org/10.1007/s00595-023-02687-9
- DOI: https://doi.org/10.1038/s41396-023-01502-0
- DOI: https://doi.org/10.3177/jnsv.69.299
- DOI: https://doi.org/10.1158/2767-9764.crc-23-0138
- DOI: https://doi.org/10.1158/1541-7786.mcr-22-0929
- DOI: https://doi.org/10.1186/s12887-023-04190-z
- DOI: https://doi.org/10.1038/s41396-023-01502-0
- DOI: https://doi.org/10.3177/jnsv.69.299
- DOI: https://doi.org/10.1158/2767-9764.crc-23-0138
- DOI: https://doi.org/10.1158/1541-7786.mcr-22-0929
- DOI: https://doi.org/10.1186/s12887-023-04190-z
- DOI: https://doi.org/10.1038/s41598-023-32512-9
- DOI: https://doi.org/10.3390/ijms24021523
- DOI: https://doi.org/10.1293/tox.2022-0143
- DOI: https://doi.org/10.1292/jvms.23-0062
- DOI: https://doi.org/10.3919/jjsa.84.1515
- DOI: https://doi.org/10.1038/s41598-023-32512-9
- DOI: https://doi.org/10.3390/ijms24021523
- DOI: https://doi.org/10.1293/tox.2022-0143
- DOI: https://doi.org/10.1292/jvms.23-0062
- DOI: https://doi.org/10.3919/jjsa.84.1515
- DOI: https://doi.org/10.3389/fped.2023.1220393
- DOI: https://doi.org/10.3919/jjsa.84.1604
- DOI: https://doi.org/10.3389/fped.2023.1220393
- DOI: https://doi.org/10.1111/vco.12954
- DOI: https://doi.org/10.1186/s12893-023-02232-y
- DOI: https://doi.org/10.3919/jjsa.84.1604
- DOI: https://doi.org/10.1111/cas.15999
- DOI: https://doi.org/10.1016/j.jpedsurg.2023.10.045
- DOI: https://doi.org/10.1186/s40792-023-01754-0
- DOI: https://doi.org/10.1007/s00595-023-02687-9
- DOI: https://doi.org/10.1111/vco.12954
- DOI: https://doi.org/10.1186/s12893-023-02232-y
- DOI: https://doi.org/10.1111/cas.15999
- DOI: https://doi.org/10.1016/j.jpedsurg.2023.10.045
- DOI: https://doi.org/10.1007/s00383-022-05125-y
- [2022] The efficacy of duloxetine depends on spinal cholinergic plasticity in neuropathic pain model ratsDOI: https://doi.org/10.1016/j.ibneur.2022.02.004
- DOI: https://doi.org/10.14411/eje.2022.012
- DOI: https://doi.org/10.1093/ehjcvp/pvac008
- DOI: https://doi.org/10.1158/1538-7445.am2022-5332
- DOI: https://doi.org/10.14989/actauroljap_68_5_139
- DOI: https://doi.org/10.1007/s00383-022-05125-y
- [2022] The efficacy of duloxetine depends on spinal cholinergic plasticity in neuropathic pain model ratsDOI: https://doi.org/10.1016/j.ibneur.2022.02.004
- DOI: https://doi.org/10.14411/eje.2022.012
- DOI: https://doi.org/10.1093/ehjcvp/pvac008
- DOI: https://doi.org/10.14411/eje.2022.003
- DOI: https://doi.org/10.1136/jitc-2022-004616
- DOI: https://doi.org/10.3389/fped.2022.1053154
- DOI: https://doi.org/10.1186/s12894-022-01153-x
- DOI: https://doi.org/10.35772/ghm.2022.01042
- DOI: https://doi.org/10.3389/fped.2022.1053154
- DOI: https://doi.org/10.1186/s12894-022-01153-x
- DOI: https://doi.org/10.35772/ghm.2022.01042
- DOI: https://doi.org/10.1089/lap.2022.0390
- DOI: https://doi.org/10.3389/fped.2022.1005879
- DOI: https://doi.org/10.18999/nagjms.84.4.716
- DOI: https://doi.org/10.1007/s00595-022-02611-7
- DOI: https://doi.org/10.1111/ases.13133
- DOI: https://doi.org/10.1007/s00383-022-05243-7
- DOI: https://doi.org/10.1007/s00383-022-05235-7
- DOI: https://doi.org/10.1093/dote/doac051.546
- DOI: https://doi.org/10.1089/lap.2022.0390
- DOI: https://doi.org/10.3389/fped.2022.1005879
- DOI: https://doi.org/10.18999/nagjms.84.4.716
- DOI: https://doi.org/10.1007/s00595-022-02611-7
- DOI: https://doi.org/10.1111/ases.13133
- DOI: https://doi.org/10.1007/s00383-022-05243-7
- DOI: https://doi.org/10.1007/s00383-022-05235-7
- DOI: https://doi.org/10.1093/dote/doac051.546
- DOI: https://doi.org/10.1093/dote/doac051.542
- DOI: https://doi.org/10.1093/dote/doac051.467
- DOI: https://doi.org/10.1111/ases.13119
- DOI: https://doi.org/10.1111/ases.13116
- [2022] Utility of tissue-specific gene expression scores for gene prioritization in Mendelian diseasesDOI: https://doi.org/10.1038/s10038-022-01071-8
- DOI: https://doi.org/10.1136/jitc-2022-004616
- DOI: https://doi.org/10.1093/dote/doac051.542
- DOI: https://doi.org/10.1093/dote/doac051.467
- DOI: https://doi.org/10.1111/ases.13119
- DOI: https://doi.org/10.1111/ases.13116
- [2022] Utility of tissue-specific gene expression scores for gene prioritization in Mendelian diseasesDOI: https://doi.org/10.1038/s10038-022-01071-8
- DOI: https://doi.org/10.1158/1538-7445.am2022-5332
- DOI: https://doi.org/10.14989/actauroljap_68_5_139
- DOI: https://doi.org/10.14411/eje.2022.003
- DOI: https://doi.org/10.1093/jrr/rrab113
- DOI: https://doi.org/10.23919/iccas52745.2021.9649779
- DOI: https://doi.org/10.23919/iccas52745.2021.9649779
- DOI: https://doi.org/10.1182/blood-2021-152050
- DOI: https://doi.org/10.1093/jrr/rrab113
- DOI: https://doi.org/10.1182/blood-2021-152050
科研費(0 件)
まだデータがありません(KAKEN 取り込み後に表示)。
所属学会・役職(0 件)
まだデータがありません(学会データ連携後に表示)。